+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
MALE
ID07343349

Improving Radiotherapy for Intermediate and High-Risk Prostate Cancer with Focal Boost and Shorter Treatment Schedules

Led by Rigshospitalet, Denmark · Updated on 2026-01-21

1016

Participants Needed

3

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating improved radiotherapy methods for men with intermediate or high-risk prostate cancer to reduce cancer spread, the need for hormone treatments, and prostate cancer death. This large randomized trial aims to find out if giving a higher radiation dose directly to tumors within the prostate and shortening the treatment schedule from 20 to 12 sessions can improve outcomes without increasing side effects. The study builds on advances in imaging and radiotherapy techniques to target tumors precisely. Participants are randomly assigned to one of four groups standard 20 treatment sessions without a boost, 20 sessions with a focal boost to tumor areas, 12 treatment sessions without a boost, or 12 sessions with a focal boost. Radiation doses vary among groups, with pelvic lymph nodes also receiving treatment. The trial uses advanced imaging like MRI and PSMA-PETCT to identify tumor lesions and guide precise radiation delivery, following national quality guidelines. During the study, participants are monitored regularly for up to 123 months after radiotherapy starts. Researchers measure outcomes including freedom from distant metastasis, biochemical relapse, time to hormone therapy, relapse-free survival, overall survival, prostate cancer-specific survival, quality of life, and treatment toxicity. Participants complete blood tests, imaging, and questionnaires at scheduled intervals to track these outcomes and side effects over time.

CONDITIONS

Brief Title

Addition of Focal Boost to Primary Radiotherapy for Prostate Cancer in 12 or 20 Fractions

Research Team

P

Peter Meidahl Petersen,, MD., PhD.

P

Peter M Petersern, MD., PhD.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here